Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | TSPO | P30536 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26264796 | 0.95 | ALDH1A1 (0.45) | LMNANPC1RAB9AMAPTTP53 | |
| SCHEMBL26222023 | 0.88 | LMNA (0.48) | LMNAMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL26217384 | 0.86 | LMNA (0.51) | LMNAMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL26264793 | 0.86 | BCL2A1 (0.46) | LMNAMAPTTP53POLBKDM4E | |
| SCHEMBL26264797 | 0.85 | LMNA (0.43) | LMNAMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL26264795 | 0.85 | LMNA (0.43) | LMNANPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL26263902 | 0.85 | EGFR (0.45) | LMNARAB9AMAPTTP53POLB | |
| SCHEMBL26264794 | 0.83 | CETP (0.44) | LMNAMAPTTP53POLBPPARG | |
| SCHEMBL26217468 | 0.80 | ALDH1A1 (0.47) | LMNANPC1RAB9AMAPTTP53 | |
| SCHEMBL26263909 | 0.79 | RAB9A (0.43) | LMNANPC1RAB9AMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399291-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399291-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399292-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC Innovations, LLC | 2023-12-14 | — | — | US | disclosed |
| US-20230399292-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC Innovations, LLC | 2023-12-14 | — | — | US | disclosed |
| US-20230399290-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399290-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230373906-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230373906-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-11-23 | — | — | US | disclosed |
| US-11814335-B1 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | PTC Innovations, LLC (US) | 2023-11-14 | — | — | US | disclosed |
| US-11814335-B1 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | PTC Innovations, LLC (US) | 2023-11-14 | — | — | US | disclosed |
| US-11806323-B2 | Topical anesthetics | PTC Innovations, LLC (US) | 2023-11-07 | — | — | US | disclosed |
| US-11786493-B2 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | PTC Innovations, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11786493-B2 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | PTC Innovations, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230285332-A1 | TOPICAL ANESTHETICS | PTC INNOVATIONS LLC (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230286905-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC Innovations, LLC | 2023-09-14 | — | — | US | disclosed |
| US-20230286905-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC Innovations, LLC | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399290-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | OPRK1, ACHE, F5 | LMNA 2285/4885MTNR1A 1840/4885MTNR1B 1782/4885 |
| US-20230399292-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | OPRM1, OPRL1, OPRK1 | LMNA 2668/4885MTNR1A 40/4885MTNR1B 111/4885 |
| US-20230399291-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | CHRM2, RXFP2, OPRM1 | LMNA 3130/4885MTNR1A 242/4885MTNR1B 255/4885 |
| US-11814335-B1 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | F8, F5, OPRM1 | LMNA 2286/4885MTNR1A 1935/4885MTNR1B 1733/4885 |
| US-20230286905-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | OPRM1, OPRL1, OPRK1 | LMNA 3532/4885MTNR1A 55/4885MTNR1B 166/4885 |
| US-20230373906-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | F5, EIF4G2, ACHE | LMNA 2318/4885MTNR1A 1187/4885MTNR1B 1246/4885 |
| US-20230285332-A1 | TOPICAL ANESTHETICS | OR10J3, ALKBH3, CHRM3 | LMNA 4264/4885MTNR1A 984/4885MTNR1B 1101/4885 |
| US-11786493-B2 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | OPRM1, OPRL1, OPRK1 | LMNA 3532/4885MTNR1A 55/4885MTNR1B 166/4885 |
| US-11806323-B2 | Topical anesthetics | OR10J3, ALKBH3, CHRM3 | LMNA 4282/4885MTNR1A 1035/4885MTNR1B 1214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.